Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingjun Wang

Showing results (321-330 of 328) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 328 results.
British Journal of Haematology|March 16, 2017
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphomaZhaoming Li, Lisha Lu, Zhiyuan Zhou, et al.
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Leukemia|January 5, 2019
Recurrent PDGFRB mutations in unicentric Castleman diseaseZhaoming Li, Xuan Lan, Chaoping Li, et al.
Nature Communications|September 19, 2019
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphomaZhaoming Li, Xudong Zhang, Weili Xue, et al.
Blood Advances|November 18, 2022
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potentialYong Li, Zijun Y Xu-Monette, Jeremy Abramson, et al.
Haematologica|August 16, 2019
Genomic and outcome analysis of adult T-cell lymphoblastic lymphomaZhaoming Li, Yue Song, Yanjie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
JAMA Oncology|June 16, 2022
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical TrialXinhua Wang, Lei Zhang, Xiangli Liu, et al.
Pageof 33

Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
British Journal of Haematology|March 16, 2017
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphomaZhaoming Li, Lisha Lu, Zhiyuan Zhou, et al.
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Leukemia|January 5, 2019
Recurrent PDGFRB mutations in unicentric Castleman diseaseZhaoming Li, Xuan Lan, Chaoping Li, et al.
Nature Communications|September 19, 2019
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphomaZhaoming Li, Xudong Zhang, Weili Xue, et al.
Blood Advances|November 18, 2022
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potentialYong Li, Zijun Y Xu-Monette, Jeremy Abramson, et al.
Haematologica|August 16, 2019
Genomic and outcome analysis of adult T-cell lymphoblastic lymphomaZhaoming Li, Yue Song, Yanjie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
JAMA Oncology|June 16, 2022
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical TrialXinhua Wang, Lei Zhang, Xiangli Liu, et al.
Pageof 33